Bank Julius Baer & Co. Ltd Zurich Buys 11,154 Shares of CME Group Inc. $CME

Bank Julius Baer & Co. Ltd Zurich raised its stake in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 1.7% in the 2nd quarter, according to its most recent disclosure with the SEC. The firm owned 654,545 shares of the financial services provider's stock after purchasing an additional 11,154 shares during the period. Bank Julius Baer & Co. Ltd Zurich owned 0.18% of CME Group worth $180,000 as of its most recent SEC filing.

• Capitalize on Volatility: 3 Finance Stocks Thriving in 2025

Other hedge funds and other institutional investors have also bought and sold shares of the company. AE Wealth Management LLC increased its holdings in CME Group by 18.4% in the 1st quarter. AE Wealth Management LLC now owns 1,095 shares of the financial services provider's stock worth $291,000 after acquiring an additional 170 shares in the last quarter. Advisor OS LLC purchased a new position in CME Group during the first quarter valued at approximately $204,000. Avantax Advisory Services Inc. boosted its position in shares of CME Group by 5.1% in the first quarter. Avantax Advisory Services Inc. now owns 19,431 shares of the financial services provider's stock worth $5,155,000 after purchasing an additional 945 shares during the period. Cetera Investment Advisers increased its stake in shares of CME Group by 18.7% in the first quarter. Cetera Investment Advisers now owns 40,196 shares of the financial services provider's stock worth $10,664,000 after purchasing an additional 6,319 shares in the last quarter. Finally, Assetmark Inc. raised its position in shares of CME Group by 4.2% during the 1st quarter. Assetmark Inc. now owns 25,081 shares of the financial services provider's stock valued at $6,654,000 after purchasing an additional 1,004 shares during the period. Hedge funds and other institutional investors own 87.75% of the company's stock.

CME Group Trading Down 0.8%

CME stock opened at $273.09 on Monday. The firm has a fifty day moving average price of $268.74 and a 200 day moving average price of $272.62. CME Group Inc. has a fifty-two week low of $224.62 and a fifty-two week high of $290.79. The firm has a market cap of $98.48 billion, a PE ratio of 26.46, a price-to-earnings-growth ratio of 4.41 and a beta of 0.38. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02.

• Morgan Stanley: 3 Financial Stocks That Will Thrive in Volatility

CME Group (NASDAQ:CME - Get Free Report) last released its quarterly earnings data on Wednesday, October 22nd. The financial services provider reported $2.68 EPS for the quarter, beating the consensus estimate of $2.63 by $0.05. CME Group had a net margin of 58.84% and a return on equity of 14.61%. The business had revenue of $1.54 billion during the quarter, compared to analyst estimates of $1.56 billion. During the same quarter last year, the business earned $2.68 earnings per share. CME Group's quarterly revenue was down 3.0% compared to the same quarter last year. Sell-side analysts anticipate that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 30th. Investors of record on Friday, December 12th will be given a $1.25 dividend. The ex-dividend date is Friday, December 12th. This represents a $5.00 annualized dividend and a yield of 1.8%. CME Group's dividend payout ratio (DPR) is currently 48.45%.

Analysts Set New Price Targets

• 4 Stocks Planning to Return Capital With Hefty Buyback Programs

Several research analysts recently weighed in on the stock. Keefe, Bruyette & Woods upped their target price on shares of CME Group from $283.00 to $287.00 and gave the stock a "market perform" rating in a report on Monday, October 13th. Citigroup raised CME Group from a "neutral" rating to a "buy" rating and upped their price objective for the stock from $275.00 to $300.00 in a research note on Thursday, September 25th. Piper Sandler lifted their target price on CME Group from $296.00 to $313.00 and gave the company an "overweight" rating in a research note on Thursday, November 13th. Rothschild & Co Redburn upped their price target on CME Group from $297.00 to $300.00 and gave the stock a "neutral" rating in a research note on Thursday, November 6th. Finally, Barclays cut their price objective on shares of CME Group from $298.00 to $280.00 and set an "equal weight" rating for the company in a report on Wednesday, October 8th. Eight equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and three have assigned a Sell rating to the company's stock. Based on data from MarketBeat, the company currently has an average rating of "Hold" and an average price target of $287.65.

Get Our Latest Report on CME

Insider Buying and Selling

In other news, insider Timothy Francis Mccourt sold 379 shares of the business's stock in a transaction that occurred on Tuesday, September 16th. The stock was sold at an average price of $259.83, for a total transaction of $98,475.57. Following the transaction, the insider owned 9,508 shares of the company's stock, valued at approximately $2,470,463.64. The trade was a 3.83% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Sunil Cutinho sold 11,896 shares of the stock in a transaction on Tuesday, August 26th. The shares were sold at an average price of $271.47, for a total value of $3,229,407.12. Following the sale, the insider owned 17,440 shares in the company, valued at $4,734,436.80. The trade was a 40.55% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 14,043 shares of company stock valued at $3,791,486 in the last quarter. 0.30% of the stock is currently owned by insiders.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

See Also

• Five stocks we like better than CME Group
• What is Forex and How Does it Work?
• DoorDash’s Recent Stock Dip Equals 60% Upside
• What Are Dividend Challengers?
• Wall Street Loves Williams-Sonoma Right Now—Here’s Why the Stock Could Soar in 2026
• Why Invest in 5G? How to Invest in 5G Stocks
• Meta Wins FTC Fight, Keeps Instagram Growth Machine Intact

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in CME Group Right Now?

Before you consider CME Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.

While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here